Press release
Gastrointestinal Drugs Market Top Players- Sanofi; GlaxoSmithKline plc; Johnson and Johnson Services, Inc.; Bausch Health
According to our new market research study on “Gastrointestinal Drugs Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Drug Class, Route of Administration, Application, and Distribution Channel,” the market is expected to reach US$ 71,300.28 million in 2027 from US$ 49,043.38 million in 2019. The market is estimated to grow at a CAGR of 4.9% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.Request Sample Copy Of this Report @ http://bit.ly/3gLRSjN
Based on drug class, the market is segmented in to acid neutralizers, antidiarrheal and laxatives, anti-inflammatory drugs, antiemetic and antinauseants, biologics, and others.
In 2019, the acid neutralizers segment held the largest share of the market. The biologics segment is expected to grow at the fastest CAGR during the forecast period. The advent of biologics has had a significant impact on the management of inflammatory bowel disease (IBD). Treatment with biologics has led to an improved quality of life for patients living with Crohn's disease and ulcerative colitis, with fewer admissions to the hospital and less side effects from corticosteroids. These are the most recently developed treatments for IBD. Biologic therapies are indicated for people with moderately to severely active disease who have not responded well to conventional therapy. Four of these agents (adalimumab, certolizumab pegol, golimumab and infliximab) target an inflammatory protein called tumor necrosis factor (TNF). Natalizumab and vedolizumab work by blocking certain types of white blood cells from getting into inflamed tissues.
The report segments global gastrointestinal drugs market as follows:
By Drug Class
• Acid Neutralizers
• Antidiarrheal and Laxatives
• Anti-Inflammatory Drugs
• Antiemetic and Antinauseants
• Biologics
• Others
By Route of Administration
• Oral
• Parenteral
By Application
• Inflammatory Ulcerative Colitis
• Crohn's Disease
• Irritable Bowel Syndrome
• Gastroenteritis
• Celiac Disease
• Others
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Gastrointestinal diseases are the conditions that occur in the gastrointestinal tract. Common digestive problems include heartburn, inflammatory bowel diseases (IBD), inflammatory bowel syndrome (IBS), constipation, and diarrhea. GI diseases account for substantial health care utilization and spending. According to the European Federation of Crohn's & Ulcerative Colitis Associations (EFCCA), around 10 million people are living with IBD worldwide. Growing prevalence of IBD can be ascribed to poor nutritional choices, including a high intake of ultra-processed foods and trans-fats.
Purchase Copy of this Report @ https://bit.ly/37hJcyg
Western countries, such as the US, Canada, and the UK, are witnessing a high GI incidence rate due to increasing obesity in the adult population and less consumption of dietary fibers. As per the Centers for Disease Control and Prevention, in 2018, the number of visits to physician offices with the digestive system's diseases as the primary diagnosis was 22.4 million in the US. The incidence and prevalence of GI disorders are higher in the adult and elderly population. As the population ages, the disease burden is expected to increase. The GI disorders, such as inflammatory bowel diseases, Crohn’s disease, and ulcerative colitis, are common, chronic inflammatory conditions that affect a vast population worldwide. This is due to a sedentary lifestyle, changing dietary habits, stress, and other factors. The incidence and prevalence of IBS have increased in the last few decades worldwide. As per the International Foundation for Gastrointestinal Disorders, Inc., IBS is the most common functional GI disorder with a prevalence rate of 10–15% globally. Also, it is one of the most common conditions for a visit to a doctor. There are around 2.4–3.5 million physician visits for IBS annually in the US. The cost of direct medical expenses and indirect costs associated with loss of productivity and work absenteeism due to IBS is estimated to be around US$ 21 billion annually
Contact:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastrointestinal Drugs Market Top Players- Sanofi; GlaxoSmithKline plc; Johnson and Johnson Services, Inc.; Bausch Health here
News-ID: 2209881 • Views: …
More Releases from Theinsightpartners.com

Total Retail Software Market Growth Prospects, Developments Plans, Future Insigh …
Total Retail Software Market Research Report 2030 is a comprehensive business study on the current state of industry which analyses innovative strategies for business growth and describes important factors such as top manufacturers, production value, key regions, growth rate. The most up to date market insights and analysis performed in this Total Retail Software report brings marketplace clearly into the focus. A lot of hard work has been put together…

Osteoarthritis Pain Drugs Market Industry Trends, Size, Share, Growth, Opportuni …
The "Osteoarthritis Pain Drugs Market to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Osteoarthritis Pain Drugs Market with detailed market segmentation by product types and end user. The Osteoarthritis Pain Drugs Market is expected to witness high growth during the forecast period. The report provides key statistics on…

Commercial Insurance Software Market Growth, Share, Regional Prospects, Opportun …
Commercial Insurance Software Market Research Report efficiently gathers information about target markets or customers. It consists of qualitative including focus groups, in-depth interviews as well as quantitative techniques that include customer survey and analysis of secondary data. Market report aids in planning business by providing information about the market. Up-to-date marketing reports help companies to have in depth analysis of industry and future trends. In this Commercial Insurance Software market…

Supplier Relationship Management Software Market Size, Development Strategy, Glo …
Supplier Relationship Management Software Market Research Report 2022 is a comprehensive business study on the current state of industry which analyses innovative strategies for business growth and describes important factors such as top manufacturers, production value, key regions, growth rate. The most up to date market insights and analysis performed in this Supplier Relationship Management Software report brings marketplace clearly into the focus. A lot of hard work has been…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…